June 22 () - Nuvectis Pharma said on Monday it had licensed exclusive rights outside China to two experimental drugs from Haisco Pharmaceutical Group, targeting complement-mediated diseases and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results